Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0980120220200010009
Annals of Phlebology
2022 Volume.20 No. 1 p.9 ~ p.14
Direct Oral Anticoagulants for Anticoagulation after Initial Management of Venous Thromboembolism
Ryu Se-Min

Park Sung-Min
Yang Se-Ran
Cho Seong-Joon
Ryu Sook-Won
Lee Seung-Hwan
Abstract
Direct oral anticoagulants for the long-term treatment of venous thromboembolisms including deep vein thrombosis and pulmonary embolism are preferred for most hemodynamically stable, non-pregnant patients who do not have severe renal insufficiency or active cancer. This preference for these medications is based on their comparable efficacy, reduced need for monitoring, and safety profile, especially when compared to warfarin in terms of major bleeding. Recent studies suggest that certain direct oral anticoagulants may be advantageous over others.
KEYWORD
Anticoagulants, Venous thromboembolism, Pulmonary embolism, Anticoagulation, Management
FullTexts / Linksout information
Listed journal information